Wird geladen...
Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
The prevalence of depression has dramatically increased, and it has been estimated that over 300 million people suffer from depression all over the world. Depression is highly comorbid with many central and peripheral disorders. In this regard, depressive states have been associated with the develop...
Gespeichert in:
| Veröffentlicht in: | Front Pharmacol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533589/ https://ncbi.nlm.nih.gov/pubmed/31156428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00483 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|